Is NF-kappaB a good target for cancer therapy? Hopes and pitfalls.

Abstract : NF-kB transcription factors have a key role in many physiological processes, such as innate and adaptive immune responses, cell proliferation, cell death, and inflammation. It has become clear that aberrant regulation of NF-kB and the signaling pathways that control its activity are involved in cancer development and progression, as well as in resistance to chemotherapy and radiotherapy. This article discusses recent evidence from cancer genetics and cancer genome studies that support the involvement of NF-kB in human cancer, particularly in multiple myeloma. The therapeutic potential and benefit of targeting NF-kB in cancer, and the possible complications and pitfalls of such an approach, are explored.
Complete list of metadatas

Cited literature [84 references]  Display  Hide  Download

https://www.hal.inserm.fr/inserm-00352349
Contributor : Veronique Baud <>
Submitted on : Friday, July 3, 2009 - 1:53:59 PM
Last modification on : Wednesday, August 7, 2019 - 12:18:06 PM
Long-term archiving on: Tuesday, June 8, 2010 - 5:46:35 PM

Files

Identifiers

Collections

Citation

Véronique Baud, Michael Karin. Is NF-kappaB a good target for cancer therapy? Hopes and pitfalls.. Nature Reviews Drug Discovery, Nature Publishing Group, 2009, 8 (1), pp.33-40. ⟨10.1038/nrd2781⟩. ⟨inserm-00352349⟩

Share

Metrics

Record views

350

Files downloads

1429